Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
Clinical trial NCT05727176 · RECRUITING
Trial details
- NCT number
- NCT05727176
- Sponsor
- Taiho Oncology, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-05
- Primary completion
- 2026-12-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.